UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Ambulatory Blood Pressure Parameters Among Men With Hypogonadism Treated With Testosterone Transdermal Therapy

Endocrine practice, 2024-06

2024

Link zum Volltext

Verfügbarkeit prüfen

A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients

Cancer prevention research (Philadelphia, Pa.), 2012-04, Vol.5 (4), p.621-630

2012

Link zum Volltext

Verfügbarkeit prüfen

LB-S&T-22 A NEW MEASURE OF NOCTURIA TREATMENT IMPACT

The Journal of urology, 2016-04, Vol.195 (4), p.e345-e345

2016

Link zum Volltext

Verfügbarkeit prüfen

A green and black tea extract benefits urological health in men with lower urinary tract symptoms

Therapeutic advances in urology, 2014-06, Vol.6 (3), p.89-96

2014

Link zum Volltext

Verfügbarkeit prüfen

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer

The New England journal of medicine, 2020-06, Vol.382 (23), p.2187-2196

2020

Link zum Volltext

Verfügbarkeit prüfen

External electrical stimulation compared with intravaginal electrical stimulation for the treatment of stress urinary incontinence in women: A randomized controlled noninferiority trial

Neurourology and urodynamics, 2019-09, Vol.38 (7), p.1834-1843

2019

Link zum Volltext

Verfügbarkeit prüfen

PCA3 Molecular Urine Test as a Predictor of Repeat Prostate Biopsy Outcome in Men with Previous Negative Biopsies: A Prospective Multicenter Clinical Study

The Journal of urology, 2013-07, Vol.190 (1), p.64-69

2013

Link zum Volltext

Verfügbarkeit prüfen

Back Cover Image, Volume 38, Number 7, September 2019

Neurourology and urodynamics, 2019-09, Vol.38 (7), p.ii-ii

2019

Link zum Volltext

Verfügbarkeit prüfen

Reply by Authors

The Journal of urology, 2023-09, Vol.210 (3), p.509-509

2023

Link zum Volltext

Verfügbarkeit prüfen

The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

The Journal of urology, 2023-09, Vol.210 (3), p.500-509

2023

Link zum Volltext

Verfügbarkeit prüfen

PD41-03 12-MONTH OUTCOMES FROM A RANDOMIZED, SHAM CONTROLLED STUDY EVALUATING A NOVEL DRUG COATED BALLOON FOR THE TREATMENT OF BPH

The Journal of urology, 2023-04, Vol.209 (Supplement 4)

2023

Link zum Volltext

Verfügbarkeit prüfen

Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial

The Lancet infectious diseases, 2014-07, Vol.14 (7), p.609-618

2014

Link zum Volltext

Verfügbarkeit prüfen

Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification

The Journal of urology, 2023-04, Vol.209 (4), p.762-772

2023

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the safety and potential activity of URO‐902 (hMaxi‐K) gene transfer by intravesical instillation or direct injection into the bladder wall in female participants with idiopathic (non‐neurogenic) overactive bladder syndrome and detrusor overactivity from two double‐blind, imbalanced, placebo‐controlled randomized phase 1 trials

Neurourology and urodynamics, 2020-02, Vol.39 (2), p.744-753

2020

Link zum Volltext

Verfügbarkeit prüfen

Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study

The Journal of urology, 2016-09, Vol.196 (3), p.791-800

2016

Link zum Volltext

Verfügbarkeit prüfen

EFFICACY AND SAFETY OF A NEW TOPICAL TESTOSTERONE REPLACEMENT GEL THERAPY FOR THE TREATMENT OF MALE HYPOGONADISM

Endocrine practice, 2017-05, Vol.23 (5), p.557-565

2017

Link zum Volltext

Verfügbarkeit prüfen

A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of OnabotulinumtoxinA 200 U to Treat Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia

The Journal of urology, 2014-07, Vol.192 (1), p.150-156

2014

Link zum Volltext

Verfügbarkeit prüfen

PD26-03 SER120 NASAL SPRAY IS EFFECTIVE IN PATIENTS WITH NOCTURIA IRRESPECTIVE OF ETIOLOGY: A POOLED ANALYSIS OF TWO RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIALS

The Journal of urology, 2017-04, Vol.197 (4), p.e507-e507

2017

Link zum Volltext

Verfügbarkeit prüfen

Fexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement

World journal of urology, 2018-05, Vol.36 (5), p.801-809

2018

Link zum Volltext

Verfügbarkeit prüfen

Effect of Tadalafil Once Daily on Prostate Blood Flow and Perfusion in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Randomized, Double-blind, Multicenter, Placebo-controlled Trial

Urology (Ridgewood, N.J.), 2014-08, Vol.84 (2), p.412-420

2014

Link zum Volltext

Verfügbarkeit prüfen

Inside Front Cover Image, Volume 39, Number 2, February 2020

Neurourology and urodynamics, 2020-02, Vol.39 (2), p.ii-ii

2020

Link zum Volltext

Verfügbarkeit prüfen

Reply by Authors

The Journal of urology, 2023-09, Vol.210 (3), p.509-509

2023

Link zum Volltext

Verfügbarkeit prüfen

Reply by Authors

The Journal of urology, 2023-09, Vol.210 (3), p.509

2023

Link zum Volltext

Verfügbarkeit prüfen

Novel Concentrated Cranberry Liquid Blend, UTI-STAT With Proantinox, Might Help Prevent Recurrent Urinary Tract Infections in Women

Urology (Ridgewood, N.J.), 2010-10, Vol.76 (4), p.841-845

2010

Link zum Volltext

Verfügbarkeit prüfen

1211 PROGENSA PCA3 PIVOTAL U.S. CLINICAL STUDY CONFIRMS UTILITY FOR PREDICTING REPEAT BIOPSY OUTCOME

The Journal of urology, 2012-04, Vol.187 (4), p.e490-e490

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ambulatory Blood Pressure Parameters Among Men With Hypogonadism Treated With Testosterone Transdermal Therapy

A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patients

LB-S&T-22 A NEW MEASURE OF NOCTURIA TREATMENT IMPACT

A green and black tea extract benefits urological health in men with lower urinary tract symptoms

Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer

External electrical stimulation compared with intravaginal electrical stimulation for the treatment of stress urinary incontinence in women: A randomized controlled noninferiority trial

PCA3 Molecular Urine Test as a Predictor of Repeat Prostate Biopsy Outcome in Men with Previous Negative Biopsies: A Prospective Multicenter Clinical Study

Back Cover Image, Volume 38, Number 7, September 2019

Reply by Authors

The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia

PD41-03 12-MONTH OUTCOMES FROM A RANDOMIZED, SHAM CONTROLLED STUDY EVALUATING A NOVEL DRUG COATED BALLOON FOR THE TREATMENT OF BPH

Effect of nitazoxanide in adults and adolescents with acute uncomplicated influenza: a double-blind, randomised, placebo-controlled, phase 2b/3 trial

Urinary Analysis of FGFR3 and TERT Gene Mutations Enhances Performance of Cxbladder Tests and Improves Patient Risk Stratification

Durable Efficacy and Safety of Long-Term OnabotulinumtoxinA Treatment in Patients with Overactive Bladder Syndrome: Final Results of a 3.5-Year Study

EFFICACY AND SAFETY OF A NEW TOPICAL TESTOSTERONE REPLACEMENT GEL THERAPY FOR THE TREATMENT OF MALE HYPOGONADISM

A Multicenter, Randomized, Double-Blind, Placebo Controlled Study of OnabotulinumtoxinA 200 U to Treat Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia

PD26-03 SER120 NASAL SPRAY IS EFFECTIVE IN PATIENTS WITH NOCTURIA IRRESPECTIVE OF ETIOLOGY: A POOLED ANALYSIS OF TWO RANDOMIZED, PLACEBO-CONTROLLED PHASE 3 TRIALS

Fexapotide triflutate: results of long-term safety and efficacy trials of a novel injectable therapy for symptomatic prostate enlargement

Effect of Tadalafil Once Daily on Prostate Blood Flow and Perfusion in Men With Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Randomized, Double-blind, Multicenter, Placebo-controlled Trial

Inside Front Cover Image, Volume 39, Number 2, February 2020

Reply by Authors

Reply by Authors

Novel Concentrated Cranberry Liquid Blend, UTI-STAT With Proantinox, Might Help Prevent Recurrent Urinary Tract Infections in Women

1211 PROGENSA PCA3 PIVOTAL U.S. CLINICAL STUDY CONFIRMS UTILITY FOR PREDICTING REPEAT BIOPSY OUTCOME

Suchergebnisse filtern